Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 311

1.

Iron supplementation in the non-dialysis chronic kidney disease (ND-CKD) patient: oral or intravenous?

Macdougall IC.

Curr Med Res Opin. 2010 Feb;26(2):473-82. doi: 10.1185/03007990903512461. Review.

PMID:
20014980
2.

2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.

Tsubakihara Y, Nishi S, Akiba T, Hirakata H, Iseki K, Kubota M, Kuriyama S, Komatsu Y, Suzuki M, Nakai S, Hattori M, Babazono T, Hiramatsu M, Yamamoto H, Bessho M, Akizawa T.

Ther Apher Dial. 2010 Jun;14(3):240-75. doi: 10.1111/j.1744-9987.2010.00836.x.

PMID:
20609178
3.

The efficacy and safety of current intravenous iron preparations for the management of iron-deficiency anaemia: a review.

Qunibi WY.

Arzneimittelforschung. 2010;60(6a):399-412. doi: 10.1055/s-0031-1296304. Review.

PMID:
20648931
4.

A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients.

Qunibi WY, Martinez C, Smith M, Benjamin J, Mangione A, Roger SD.

Nephrol Dial Transplant. 2011 May;26(5):1599-607. doi: 10.1093/ndt/gfq613. Epub 2010 Oct 7.

5.

Intravenous versus oral iron supplementation for the treatment of anemia in CKD: systematic review and meta-analysis.

Rozen-Zvi B, Gafter-Gvili A, Paul M, Leibovici L, Shpilberg O, Gafter U.

Am J Kidney Dis. 2008 Nov;52(5):897-906. doi: 10.1053/j.ajkd.2008.05.033. Epub 2008 Oct 8. Review.

PMID:
18845368
6.

Considerations for optimal iron use for anemia due to chronic kidney disease.

Hudson JQ, Comstock TJ.

Clin Ther. 2001 Oct;23(10):1637-71. Review.

PMID:
11726002
7.

Iron therapy in chronic kidney disease: current controversies.

Kovesdy CP, Kalantar-Zadeh K.

J Ren Care. 2009 Dec;35 Suppl 2:14-24. doi: 10.1111/j.1755-6686.2009.00125.x. Review.

PMID:
19891681
8.

Use of intravenous iron supplementation in chronic kidney disease: an update.

Macdougall IC, Geisser P.

Iran J Kidney Dis. 2013 Jan;7(1):9-22. Review.

9.

EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.

Bokemeyer C, Aapro MS, Courdi A, Foubert J, Link H, Osterborg A, Repetto L, Soubeyran P; European Organisation for Research and Treatment of Cancer (EORTC) Taskforce for the Elderly.

Eur J Cancer. 2007 Jan;43(2):258-70. Epub 2006 Dec 19. Review.

PMID:
17182241
10.

The safety and efficacy of intravenous ferric carboxymaltose in anaemic patients undergoing haemodialysis: a multi-centre, open-label, clinical study.

Covic A, Mircescu G.

Nephrol Dial Transplant. 2010 Aug;25(8):2722-30. doi: 10.1093/ndt/gfq069. Epub 2010 Feb 26.

11.

Strategies for iron supplementation: oral versus intravenous.

Macdougall IC.

Kidney Int Suppl. 1999 Mar;69:S61-6. Review.

PMID:
10084288
12.

The efficacy of a single dose of intravenous ferric carboxymaltose (Ferinject) on anaemia in a pre-dialysis population of chronic kidney disease patients.

Tagboto S, Cropper L, Turner J, Pugh-Clarke K.

J Ren Care. 2009 Mar;35(1):18-23. doi: 10.1111/j.1755-6686.2009.00075.x.

PMID:
19200274
13.

[IV iron or oral iron in anaemic patient with CKD].

Frimat L, Thilly N, Boini S.

Nephrol Ther. 2006 Nov;2 Suppl 5:S347-9. French.

PMID:
17373282
14.

Intravenous versus oral iron for treatment of iron deficiency in non-hemodialysis-dependent patients with chronic kidney disease.

Liles AM.

Am J Health Syst Pharm. 2012 Jul 15;69(14):1206-11. doi: 10.2146/ajhp110231. Review.

PMID:
22761074
16.

[Use of intravenous iron supplementation in chronic kidney disease: Interests, limits, and recommendations for a better practice].

Rottembourg J, Rostoker G.

Nephrol Ther. 2015 Dec;11(7):531-42. doi: 10.1016/j.nephro.2015.04.009. Epub 2015 Oct 20. Review. French.

PMID:
26498106
17.

Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial.

Van Wyck DB, Mangione A, Morrison J, Hadley PE, Jehle JA, Goodnough LT.

Transfusion. 2009 Dec;49(12):2719-28. doi: 10.1111/j.1537-2995.2009.02327.x. Epub 2009 Jul 22.

PMID:
19682342
18.

Iron replacement and supplementation in patients with chronic kidney disease.

Wazny LD, Raymond CB.

CANNT J. 2011 Oct-Dec;21(4):26-30; quiz 31-2.

PMID:
22324122
19.

Intravenous iron supplementation for the treatment of anaemia in pre-dialyzed chronic renal failure patients.

Mircescu G, Gârneata L, Capusa C, Ursea N.

Nephrol Dial Transplant. 2006 Jan;21(1):120-4. Epub 2005 Sep 6.

PMID:
16144853
20.

FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia.

Macdougall IC, Bock AH, Carrera F, Eckardt KU, Gaillard C, Van Wyck D, Roubert B, Nolen JG, Roger SD; FIND-CKD Study Investigators.

Nephrol Dial Transplant. 2014 Nov;29(11):2075-84. doi: 10.1093/ndt/gfu201. Epub 2014 Jun 2.

Supplemental Content

Support Center